Daily Healthcare St. Lucia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Daily Healthcare St. Lucia.

Press releases published on July 21, 2026

Jul. 21, 2026

European Patent Office Confirms Patent Protection for SOT201, SOTIO's Clinical-Stage Immunocytokine Showing Promising Anti-Tumor Activity

Indeterminate GlobeNewswire

Jul. 21, 2026

PatientsLikeMe and Science 37 Partner to Unlock Trial Access for Interested, Eligible Patients

Indeterminate GlobeNewswire

Jul. 21, 2026

Senseonics Holdings, Inc. Schedules Second Quarter 2026 Earnings Release and Conference Call for August 6, 2026 at 4:30 P.M. Eastern Time

Indeterminate GlobeNewswire

Jul. 21, 2026

Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers

Indeterminate GlobeNewswire

Jul. 21, 2026

Vivex Biologics Launches VIA Linx™, a Novel Self-Assembling Synthetic Peptide Matrix, Expanding its Portfolio of Advanced Wound Care Solutions

Indeterminate GlobeNewswire

Jul. 21, 2026

Smile Doctors Appoints Jeff Knudson as CFO to Help Scale Next Phase of Growth

Indeterminate GlobeNewswire

Jul. 21, 2026

AssistRx and Medisafe Unite to Power Smarter, More Connected Patient Engagement

Indeterminate GlobeNewswire

Jul. 21, 2026

 VYNE Therapeutics Announces 1-for-50 Reverse Stock Split and Provides Update Regarding Special Dividend in Connection with the Proposed Merger with Yarrow Bioscience

Indeterminate GlobeNewswire

Jul. 21, 2026

Verrica Pharmaceuticals and Medomie Pharma Enter into Exclusive Distribution, Marketing and Supply Agreement to Commercialize YCANTH® for the Treatment of Molluscum Contagiosum in Israel

Indeterminate GlobeNewswire

Jul. 21, 2026

Vaxart to Participate in BTIG Biotechnology Conference 2026

Indeterminate GlobeNewswire

Jul. 21, 2026

Cadrenal Therapeutics Launches Partnering Process as Its Cardiac Acute Critical Care Assets Advance to Transaction Readiness Following Landmark ISTH Data Presentation

Indeterminate GlobeNewswire

Jul. 21, 2026

Helus Pharma Completes Enrollment in Phase 3 APPROACH Study of HLP003 in Adjunctive Treatment of Major Depressive Disorder Ahead of Schedule

Indeterminate GlobeNewswire

Jul. 21, 2026

Novo Nordisk takes action to stop multiple misleading national GLP-1 advertising campaigns by Eli Lilly

Indeterminate GlobeNewswire

Jul. 21, 2026

PolyPid Announces Exclusive Partnership with Azurity Pharmaceuticals for the Commercialization of D-PLEX₁₀₀ in the U.S. and Canada

Indeterminate GlobeNewswire

Jul. 21, 2026

Plus Therapeutics Secures Regional Coverage Agreement with Medical Mutual for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer

Indeterminate GlobeNewswire

Jul. 21, 2026

Rezolute to Participate in the BTIG Virtual Biotechnology Conference

Indeterminate GlobeNewswire

Jul. 21, 2026

Cronos’ SOURZ by Spinach® Expands its Lineup of Edibles

Indeterminate GlobeNewswire

Jul. 21, 2026

Cincinnati Children's Activated as the Seventh Qualified Treatment Center for ZEVASKYN®

Indeterminate GlobeNewswire

Jul. 21, 2026

Alterity Therapeutics to Participate in the Virtual BTIG Biotechnology Conference 2026

Indeterminate GlobeNewswire

Jul. 21, 2026

Jupiter Neurosciences (NASDAQ: JUNS) Signs Definitive Agreement for Exclusive U.S. Rights to ALA-002 in Transaction Valued at Up to $100 Million

Indeterminate GlobeNewswire